STATE OF NEW YORK
________________________________________________________________________
6542
2023-2024 Regular Sessions
IN SENATE
April 26, 2023
___________
Introduced by Sen. RIVERA -- read twice and ordered printed, and when
printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to newborn screening
for glucose-6-phosphate dehydrogenase deficiency
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Paragraph (j) of subdivision 1 of section 2500-a of the
2 public health law, as amended by chapter 70 of the laws of 2022, is
3 amended to read as follows:
4 (j) Glucose-6-phosphate dehydrogenase deficiency [using a quantitative
5 enzymatic test or other diagnostic test in cases where: the newborn
6 infant presents with hemolytic anemia, hemolytic jaundice, or early-on-
7 set increasing neonatal jaundice, that is, jaundice (bilirubin level
8 greater than fortieth percentile for age in hours) persisting beyond the
9 day of birth through the week after birth; the newborn infant has been
10 admitted to the hospital for jaundice following birth; or the biological
11 parent of the newborn infant indicates a family, racial, or ethnic risk
12 of glucose-6-phosphate dehydrogenase deficiency, including having
13 significant African, Asian, Mediterranean, or Middle Eastern ancestry].
14 § 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD10869-02-3
